13006-69-4

Basic information

• Product Name: lincosamine
• Synonyms: lincosamine
• CAS NO: 13006-69-4
• Molecular Formula: C8H17NO6
• Molecular Weight: 223.22368
• Mol File: 13006-69-4.mol
• Article Data: 0

Chemical Properties

• Boiling Point: 485.4°Cat760mmHg
• Flash Point: 247.4°C
• Appearance: /
• Density: 1.604g/cm³
• Vapor Pressure: 1.85E-11mmHg at 25°C
• Refractive Index: 1.636
• CAS DataBase Reference: lincosamine(CAS DataBase Reference)
• NIST Chemistry Reference: lincosamine(13006-69-4)
• EPA Substance Registry System: lincosamine(13006-69-4)

Safety Data

• Hazardous Substances Data: 13006-69-4(Hazardous Substances Data)

Usage

InChI:InChI=1/C8H17NO6/c1-2(10)3(9)7-5(12)4(11)6(13)8(14)15-7/h2-8,10-14H,9H2,1H3/t2-,3-,4+,5-,6-,7-,8?/m1/s1

Related news

Regio- and stereoselective conjugate addition of nitrogen nucleophiles to 2-alkenyl n-methylthiazolium iodides. synthesis of d-3-epi-daunosamine and some lincosamine (cas 13006-69-4) analogues09/02/2019

A two-carbon homologation-amination technology of aldehydes is described. Key steps involve the Michael-type addition of a nitrogen nucleophile (benzylamine, trimethylsilylazide, potassium phtalimide) to a 2-alkenyl N-methylthiazolium salt obtained by olefination of the aldehyde with the phospho...detailed

Stereocontrolled introduction of an amino group at C-6 of d-galactose via (3,3)-sigmatropic rearrangements—novel synthesis of lincosamine (cas 13006-69-4) and 7-epi-lincosamine (cas 13006-69-4) precursors08/31/2019

A new and stereoselective route to the aminoglycoside components of the antibiotics lincomycin and clindamycin is presented. The key step involves diastereoselective introduction of the amino group at C-6 of d-galactose by (3,3)-sigmatropic rearrangements of the corresponding allylic (Z)-trifluo...detailed

Synthesis of α-azido aldehydes Stereoselective access to a protected lincosamine (cas 13006-69-4) analogue08/29/2019

Reaction of ketone 3 with dichloromethyllithium gave a unique branched-chain dichloromethyl sugar 7 whose structure was ascertained by X-ray crystallography. Transformation of 7 in seven steps, involving the key-intermediate α-azido-aldehyde 9, afforded the protected lincosamine analogue 14.detailed